Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer

NCT01023204 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb